Guggenheim Reiterates Buy on Exelixis, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Michael Schmidt has reiterated a 'Buy' rating on Exelixis (NASDAQ:EXEL) and maintained a price target of $30.
October 11, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exelixis has received a reiterated 'Buy' rating from Guggenheim, with a maintained price target of $30.
The reiterated 'Buy' rating and maintained price target by Guggenheim indicates a positive outlook for Exelixis. This could potentially lead to increased investor confidence and a positive impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100